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Evaluation of pediatric rheumatology
telehealth satisfaction during the COVID-19
pandemic
Lindsay N. Waqar-Cowles1,2,3*, John Chuo4,5, Pamela F. Weiss1,2,5, Sabrina Gmuca1,2,5,6, Marianna LaNoue7 and
Jon M. Burnham1,5

Abstract
Background: During the Coronavirus disease 2019 pandemic, ambulatory pediatric rheumatology healthcare
rapidly transformed to a mainly telehealth model. However, pediatric patient and caregiver satisfaction with broadly
deployed telehealth programs remains largely unknown. This study aimed to evaluate patient/caregiver satisfaction
with telehealth and identify the factors associated with satisfaction in a generalizable sample of pediatric
rheumatology patients.
Methods: Patients with an initial telehealth video visit with a rheumatology provider between April and June 2020
were eligible. All patients/caregivers were sent a post-visit survey to assess a modified version of the Telehealth
Usability Questionnaire (TUQ) and demographic and clinical characteristics. TUQ total and sub-scale (usefulness,
ease of use, effectiveness, satisfaction) scores were calculated and classified as “positive” based on responses of
“agree” or “strongly agree” on a 5-point Likert scale. Results were analyzed using standard descriptive statistics and
Wilcoxon signed rank testing. The association between demographic and clinical characteristics with TUQ scores
was assessed using univariate linear regression.
Results: 597 patients/caregivers met inclusion criteria, and the survey response rate was 42% (n = 248). Juvenile
idiopathic arthritis was the most common diagnosis (33.5%). The majority of patients were diagnosed greater than
6 months previously (72.6%) and were prescribed chronic medications (59.7%). The median total TUQ score was 4
(IQR: 4–5) with positive responses in 81% of items. Of the subscales, usefulness scores were lowest (median: 4, p <
0.001). Telehealth saves time traveling was the highest median item score (median = 5, IQR: 4–5). Within subscales,
items that scored significantly lower included convenience, providing for needs, seeing rheumatologist as well as in
person, and being an acceptable way to receive rheumatology services (all p < 0.001). There were no significant
demographic or clinical features associated with TUQ scores.
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Conclusions: Our results suggest telehealth is a promising mode of healthcare delivery for pediatric rheumatic
diseases but also identifies opportunities for improvement. Innovation and research are needed to design a
telehealth system that delivers high quality and safe care that improves healthcare outcomes. Since telehealth is a
rapidly emerging form of pediatric rheumatology care, improved engagement and training of patients, caregivers,
and providers may help improve the patient experience in the future.
Keywords: COVID-19, Patient satisfaction, Telehealth, Telehealth usability questionnaire, Pediatric rheumatology

Background
In the wake of the Coronavirus disease 2019 (COVID19) pandemic, ambulatory pediatric rheumatology
healthcare delivery rapidly transformed to a mainly telehealth model at many centers using telephone and webbased video platforms [1]. Optimally used, telehealth
may improve access to care, reduce time traveling to
and from office visits, and improve cost-effectiveness.
Potential drawbacks may include lower quality patient/
clinician interactions and less accurate medical assessments [2, 3]. Given its widespread implementation and
perceived feasibility [3], telehealth will be more commonly used in the future. However, the impact on patient satisfaction in pediatric rheumatology is unknown.
While telehealth has been examined in adult rheumatology and other pediatric subspecialties [4–6], studies
characterizing and assessing pediatric rheumatology telehealth implementation are sparse and were conducted
prior to the COVID-19 pandemic. In one study, families
completed a survey that demonstrated a preference for
in-person visits, but most respondents were not familiar
with telemedicine as a modality [7]. A second study
assessed differences in costs associated with telemedicine
and found that pediatric rheumatology patients traveling
to a remote site with a nurse-facilitator accrued lower
costs and fewer hours of missed school and work [8]. Of
eligible respondents receiving standard in-person care,
only 42% expressed an interest in a telemedicine model
[8]. To date, no studies have systematically evaluated patient/caregiver telehealth satisfaction in a diverse sample
of pediatric rheumatology patients.
The purpose of this survey study was to evaluate
pediatric rheumatology telehealth visits from the patient/caregiver perspective after telehealth implementation during the COVID-19 pandemic. Our specific
objectives were to assess telehealth usefulness, ease of
use, effectiveness, and satisfaction and identify clinical
characteristics associated with overall satisfaction from
the patient/caregiver perspective.
Methods
Study participants

All patients, both new and existing, with an initial telehealth video visit with a Children’s Hospital of Philadelphia (CHOP) rheumatology provider between 4/8/2020

and 6/30/2020 and had a valid email address in their
medical record were eligible. Approximately 4% of patients did not have a valid email address, and therefore,
did not receive the survey. Patients 18 years of age or
older were allowed to complete the survey independently. Otherwise, a parent/caregiver completed the survey. This study was reviewed by the Children’s Hospital
of Philadelphia Institutional Review Board (IRB) and was
deemed not human subjects research since no protected
health information was collected.
Telehealth visit process

During the Spring of 2020, we developed a new telehealth visit process in response to the COVID-19 pandemic. Upon scheduling a video visit, a clinic
coordinator ensured registration with the electronic
health record (EHR) portal and distributed a standard
set of pre-visit recommendations. Using the built-in telehealth capabilities of the health system’s EHR, the patient/family accessed the visit through the portal using a
mobile phone, tablet, laptop, or desktop computer. The
provider accessed the visit using either a mobile phone
or tablet using mobile EHR functionality. Patient aftervisit instructions were available through the EHR portal.
Between 3/16/2020–4/13/2020, approximately 10% of
visits were in-person, which included new patient and
emergent patient visits. On 4/14/2020, new patient visits
were also converted to telehealth, and thereby, received
the survey.
Survey administration

Within one day of completing the telehealth visit, all patients/caregivers were sent an anonymous post-visit Research Electronic Data Capture (REDCap©) telehealth
satisfaction survey composed of a modified version of
the Telehealth Usability Questionnaire (TUQ) and the
Telemedicine Satisfaction and Usefulness Questionnaire
(TSUQ) [9, 10]. Patient demographic and disease-related
questions such as age, race, rheumatologic condition,
diagnosis within past 6 months, and current rheumatologic medication(s) were included. After beginning survey administration, an additional question was added to
differentiate between new and existing patients [see
Additional file 1 for the complete survey]. The survey
was automatically resent to patients/caregivers weekly
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up to three times until completed without the ability to
skip questions.
Data collection

The TUQ was chosen to assess telehealth usefulness,
ease of use, effectiveness, reliability, and satisfaction. The
TUQ has shown good internal consistency and independent content validity [9]. The TUQ includes 21 questions that are grouped into the five domains/sub-scales.
Standardized Cronbach’s coefficient alpha values for the
usefulness, ease of use, effectiveness, reliability, and satisfaction sub-scales are 0.85, 0.93, 0.87, 0.81, and 0.92, respectively [9]. The usefulness sub-scale gauges how the
patient or parent perceives potential intended benefits of
the telehealth system and whether the degree to which
the healthcare interaction or service is similar to the inperson encounter. The ease of use sub-scale quantifies
the patient or parent perception of how easy the telehealth system is to learn and whether the interaction
with the telehealth interface is enjoyable. The effectiveness sub-scale assesses the quality of the telehealth interaction, specifically around audio and visual
communication. Finally, the satisfaction sub-scale evaluates the patient’s overall satisfaction and willingness to
use the system in the future [9]. We adapted the TUQ
to include 14 questions focusing on our assessment priorities and eliminated telehealth platform questions less
germane to our clinic-based improvement efforts. We
substituted one item of the TUQ (“telehealth improves
my access to health services”) with one item from the
TSUQ (“video visits are a convenient form of healthcare
delivery for me”) in the usefulness domain, since it
assessed the information we were seeking to obtain from
patients and families more clearly. Survey questions were
delivered using a 5-point Likert scale with anchors
strongly disagree [1] and strongly agree [5] and was only
available in English.
Survey analysis

Standard descriptive statistics were used to characterize
the study population respondent demographic, diseaseand medication related variables along with TUQ total
and sub-scale scores. Likert scale responses of agree or
strongly agree were classified as positive. Responses of
neither agree or disagree, disagree, or strongly disagree
were classified as neutral or negative. The Wilcoxon
signed rank test was used to assess differences between
individual survey items within each sub-scale and differences between total sub-scale scores. Univariate linear
regression models were used to assess the association of
demographic and underlying diagnosis with TUQ total
and sub-scale scores. Bonferroni correction was used in
the exploratory analysis of differences across clinical
characteristics given there were multiple comparisons.
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Analyses were performed using IBM SPSS Statistics
20.0.

Results
Patient characteristics

We received responses from 42% (248/597) of patients
and caregivers. The demographic, disease- and treatment
characteristics, and visit type are detailed in Table 1.
The most common rheumatic condition represented was
juvenile idiopathic arthritis (JIA, 33.5%). Most were diagnosed with a rheumatologic condition greater than six
months prior to the survey (76.2%) and were taking a
medication prescribed by the rheumatologist (59.7%). Of
those on medication, steroids were prescribed for 14.5%.
Characteristics of the non-responders were not assessed,
since the survey was anonymous.
Assessment of Total TUQ and sub-scale scores

We graphically depicted positive responses across the
total TUQ and subscales (Fig. 1). There was no statistically significant difference between positive responses of
Table 1 Patient demographics, disease, and treatment
characteristics
Variable

N = 248a

Patient Age
≤ 5 years

35 (14.1%)

6–12 years

68 (27.4%)

13–17 years

118 (47.6%)

≥ 18 years

27 (10.9%)

Race
Caucasian

188 (75.8%)

African American

16 (6.5%)

Asian

17 (6.9%)

Other

27 (10.9%)

Condition
Juvenile idiopathic arthritis

83 (33.5%)

Systemic lupus erythematosus

16 (6.5%)

Inflammatory diseaseb

40 (16.1%)

Amplified musculoskeletal pain

36 (14.5%)

Other/Unknown

73 (29.4%)

Rheumatologic diagnosis in the past 6 months

59 (23.8%)

Prescribed rheumatologic medication(s)

148 (59.7%)

Glucocorticoid therapy for rheumatologic condition

36 (14.5%)

Rheumatology new patient visit (n = 212)

85 (40.1%)

a

Unless otherwise indicated
Diagnoses included in the “inflammatory disease” category include Sjogren
syndrome, vasculitis, juvenile dermatomyositis, chronic nonbacterial
osteomyelitis, idiopathic uveitis, localized scleroderma, systemic sclerosis,
Behcet syndrome, sarcoidosis, and periodic fever syndrome or
auto-inflammatory disorder
b
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Fig. 1 Graphic Depiction of Positive Response by Telehealth Usability Questionnaire (TUQ)

agree and strongly agree or negative responses of disagree or strongly disagree.
We then assessed the total TUQ and subscale scores
to identify the determinants of the telehealth satisfaction
(Table 2). The median total TUQ score was 4 (IQR: 4–
5). Patients and caregivers provided positive responses in
81% of items. Of the subscales, usefulness scores were
lowest (p < 0.001).
We next assessed differences in domain-specific responses. Within the usefulness domain, a high proportion attested to telehealth visits saving time (median = 5,
IQR: 4–5). However, scores for telehealth visits being
more convenient (median = 4, IQR: 3–5) and providing
for rheumatology needs (median = 4, IQR: 3–4) were significantly lower (p < 0.001 for both). Within the ease of
use domain, a high proportion found the interaction
pleasant and simple and easy (median = 5, IQR: 4–5 for
both). Significantly lower scores were noted for “like
using platform” (median = 4, IQR: 3–5); p < 0.001).
Within the effectiveness domain, verbal communication
items all received high scores (median = 5, IQR: 4–5),
but the visual communication scores (median = 4, IQR:
3–5) were significantly lower (p < 0.001). Within the satisfaction domain, patients and caregiver scores for comfort communicating, future use, and overall satisfaction

were high (median = 4, IQR: 4–5). However, when asked
whether telehealth is an acceptable way to receive
rheumatology services, scores (median = 4, IQR: 3–5)
were significantly lower (p < 0.001).
Clinical characteristics and satisfaction

Descriptive analysis of positive responses by demographic and clinical features across total and sub-scale
TUQ scores are depicted in Table 3. We graphically
depicted positive responses for total TUQ across demographic and patient-specific factors (Fig. 2).
The univariate regression model did not reveal differences in the telehealth satisfaction total or subscale
scores according to age, race, rheumatologic condition,
disease duration, glucocorticoid therapy or visit type.

Discussion
We completed a survey assessing telehealth satisfaction
in a diverse sample of pediatric rheumatology patients
during the COVID-19 pandemic. This is the first study
of its type and is timely given the rapid and widespread
telehealth implementation in the United States. The
study is strengthened by the use of validated telehealth
usability instruments. While overall satisfaction with
video visits was high, our data suggest that purposeful

Waqar-Cowles et al. Pediatric Rheumatology

(2021) 19:170

Page 5 of 9

Table 2 Total TUQ and Sub-Scale Scores
Positive Responsea
N (%)

Neutral / Negative Response
N (%)

Mean (SD)

Median (IQR)

Total TUQ Score

201 (81%)

47 (19%)

4.18 (0.65)

4 (4–5)

Usefulness

181 (73%)

67 (27%)

4.04 (0.72)

4 (4–5) b

1. Saves time traveling

233 (94%)

15 (6%)

4.62 (0.61)

5 (4–5)

2. More convenient

151 (61%)

97 (39%)

3.77 (1.06)

4 (3–5) c

3. Provides for needs

156 (63%)

92 (37%)

3.75 (0.95)

4 (3–4) c

Ease of Use

213 (86%)

35 (14%)

4.29 (0.69)

4 (4–5)

4. Interaction is pleasant

223 (90%)

25 (10%)

4.42 (0.74)

5 (4–5)

5. Like using platform

186 (75%)

62 (25%)

4.02 (0.95)

4 (3–5) d

6. Simple and easy

228 (92%)

20 (8%)

4.40 (0.70)

5 (4–5)

Effectiveness

211 (85%)

37 (15%)

4.26 (0.77)

5 (4–5)

7. Easily talk to rheumatologist

228 (92%)

20 (8%)

4.42 (0.84)

5 (4–5)

8. Hear rheumatologist clearly

223 (90%)

25 (10%)

4.37 (0.92)

5 (4–5)

9. Able to express myself effectively

231 (93%)

17 (7%)

4.50 (0.69)

5 (4–5)

10. See rheumatologist as well as in person

166 (67%)

82 (33%)

3.77 (1.14)

4 (3–5) e

201 (81%)

47 (19%)

4.12 (0.74)

4 (4–5)

11. Comfortable communicating

221 (89%)

27 (11%)

4.31 (0.75)

4 (4–5)

12. Acceptable way to receive rheumatology services

156 (63%)

92 (37%)

3.72 (1.09)

4 (3–5) f

13. Would use telehealth services again

216 (87%)

32 (13%)

4.26 (0.81)

4 (4–5)

14. Overall satisfied

208 (84%)

40 (16%)

4.20 (0.78)

4 (4–5)

Satisfaction

Positive response includes “agree” or “strongly agree”, while neutral/negative response includes “Neither agree nor disagree”, “disagree” and “strongly disagree”
b
Median statistically significantly lower compared with ease of use, effectiveness, and satisfaction sub-scales
c
Medians statistically significantly lower compared with item 1
d
Median statistically significantly lower compared with items 4 and 6
e
Median statistically significantly lower compared with items 7, 8, and 9
f
Median statistically significantly lower compared with items 11, 13, and 14
a

efforts will be required to design a care experience to
meet the needs of patients and families.
There are encouraging signs that telehealth may be a
viable method to deliver pediatric rheumatology care in
the future. Across all telehealth assessment sub-scales,
the majority of patients and caregivers reported positive
experiences. A high proportion considered video visits
to be time saving as well as easy to learn and use. We
did not identify significant differences in the satisfaction
based on rheumatologic diagnoses (e.g. JIA or amplified
musculoskeletal pain syndrome), medication treatments,
or demographic factors, which should be promising for
communities where access to pediatric rheumatology
providers is limited.
Although generally well-received, there was a lower
percentage of patients and caregivers who endorsed the
visits as more convenient or as an “acceptable” way to
receive pediatric rheumatology care. These findings are
consistent with a previous survey performed at a
pediatric rheumatology center demonstrating that inperson visits were preferred over telehealth regardless of
the need for travel. However, patients and families who
had more familiarity with telehealth care were more

likely to consider it equal or preferable to in-person
visits [7]. Acceptability may increase with greater exposure to video visits and application in more targeted use
cases. In addition, our study was performed during a
rapid implementation of video visits at the beginning of
the COVID-19 pandemic. It is possible that acceptability
will increase when pediatric rheumatology providers
have more familiarity with telehealth delivery and identify more optimal use cases. Research and innovation are
needed to determine how evolving telehealth technology
can help providers perform virtual exams with high fidelity and safety, thereby improving pediatric rheumatology telehealth delivery [11].
Previous studies of patient satisfaction may help identify methods to improve telehealth implementation.
While little has been published on the specific drivers of
patient satisfaction with in-person pediatric rheumatology care, drivers of a positive patient experience in the
pediatric literature include the efficiency of the visit and
more important, communication between team members and between the patient, caregivers, and healthcare
provider [12–14]. Within the realm of telehealth, the
drivers of patient satisfaction are less defined. A
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Table 3 Positive telehealth satisfaction according to demographic and patient-specific factors
Variable

Total Score

Usefulness

Ease of Use

Effectiveness

Satisfaction/ Future Use

0–5 years

83%

65%

90%

90%

85%

6–12 years

83%

73%

87%

87%

86%

13–17 years

82%

76%

86%

85%

80%

18+ years

73%

69%

75%

76%

70%

Caucasian

81%

73%

86%

84%

81%

African American

88%

77%

90%

97%

88%

Asian

85%

79%

86%

90%

84%

Other

77%

62%

84%

86%

76%

JIA

79%

68%

85%

84%

80%

SLE

85%

81%

88%

88%

83%

Inflammatory diseaseb

82%

73%

89%

84%

82%

AMPS

79%

76%

78%

83%

78%

Other/Unknown

83%

74%

88%

89%

82%

Within 6 months

84%

76%

89%

86%

84%

Greater than 6 months

81%

72%

85%

85%

80%

82%

73%

87%

87%

82%

82%

75%

88%

84%

81%

Age

Race

a

Condition

Time since diagnosis

Prescribed rheumatologic medication(s)
Yes (n = 148)
Glucocorticoid therapy
No glucocorticoid therapy

83%

73%

87%

87%

83%

80%

72%

84%

84%

79%

New

80%

70%

86%

86%

79%

Established

80%

72%

83%

84%

80%

No
Rheumatology visit type (n = 212)

Positive satisfaction defined as responses of “agree” and “strongly agree”
a
JIA: juvenile idiopathic arthritis; SLE: systemic lupus erythematosus; AMPS: amplified musculoskeletal pain syndrome
b
Diagnoses included in the “inflammatory disease” category include Sjogren syndrome, vasculitis, juvenile dermatomyositis, chronic nonbacterial osteomyelitis,
idiopathic uveitis, localized scleroderma, systemic sclerosis, Behcet syndrome, sarcoidosis, and periodic fever syndrome or auto-inflammatory disorder

systematic review of patient satisfaction with telehealth
demonstrated its potential, documenting that it was convenient, easy to use, enhanced communication, and in
some cases, improved outcomes [15]. In the included research studies, however, telehealth was mainly used to
augment management in specific chronic diseases (e.g.
sleep apnea) or support specific clinical functions (e.g.
insulin therapy monitoring). Broader applications to
general populations such as ours are less well studied.
Pediatric subspecialty-specific guidance to enhance telehealth satisfaction has been published for gastroenterology and rheumatology [16, 17]. The authors suggest
that close attention to the pre-visit process, patientfacing technology logistics, visit location, history and
physical exam completeness, and post-visit recommendations are critical to achieve a positive patient

experience. Provider and staff training will undoubtedly
be required to perform these functions optimally.
Improved clinical evaluation tools and enhanced understanding of telehealth capabilities are needed to arrive at the ideal telehealth encounter for all pediatric
rheumatology patients. Patient reported outcomes
(PROs) are being increasingly used as clinical measures to assess disease activity in pediatric rheumatology. The Juvenile Arthritis Disease Activity Score
(JADAS), for example, combines patient reported
values with physician and physical exam values to calculate disease state in JIA [18]. Telehealth visits pose
a challenge to the standard physical exam, which has
been superior in care delivery. Therefore, alternative
approaches may be needed to augment the clinical
exam to improve satisfaction with the telehealth visit.
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Fig. 2 Positive Telehealth Satisfaction Across Demographic and Patient-Specific Factors

Examples may include use of the Juvenile Arthritis
Multidimensional Assessment Report (JAMAR) for
patient-reported assessment of disease, the video
paediatric gait arms legs and spine (v-pGALS) for virtual musculoskeletal examination, and personal devices such as blood pressure monitors and symptom
trackers [17, 19]. Additionally, it will be important to
address equity issues related to internet and hardware
access, insurance status, limited language proficiency,
and health literacy in future quantitative and qualitative work to ensure the telehealth experience is optimal for all patients requiring pediatric rheumatology
care [20].
Our study had several limitations to consider. Given
the telehealth platform was rapidly deployed and changed during the study period, improved training and implementation for patients, caregivers, and providers may
help increase satisfaction in the future. Additionally, responses may have been influenced by the social context
of the COVID-19 pandemic and therefore may not be
generalizable. We received responses from 42% of patients and caregivers who may represent a more engaged
cohort and be less representative of the pediatric

rheumatology population. Since we did not have access
to personal health information, we were unable to compare the demographics of patients that responded to the
survey to those that did not respond. In addition, those
unable to access care during the pandemic and those
without an active email address were not included in the
study. Therefore, it is possible that we are capturing a
group of patients that were more likely to be satisfied
with telehealth. For example, patients may have canceled
or not participated in telehealth visits and would not
have received a satisfaction survey. Also, the survey was
only available in English, which may have excluded nonEnglish speakers from responding. There was a brief
period during survey administration where the type of
visit was not assessed. However, analysis of visit type
and satisfaction showed no significant difference indicating that it was appropriate to include all of the data together. There may be additional constructs of
satisfaction with telehealth, such as technological reliability, that were not addressed by our survey that could
benefit from future analysis. Finally, the physician perspective regarding usability of and satisfaction with telehealth for specific visit-level processes and patient
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populations was not assessed and would be impactful to
include in future research studies.

Conclusions
These data provide the foundation for understanding patient and caregivers’ satisfaction with telehealth in pediatric
rheumatology and suggest that it is a promising mode of
healthcare delivery. Further work is needed to design specific telehealth processes for pediatric rheumatology populations and assess outcomes. Given that telehealth is a
rapidly emerging form of pediatric rheumatology care, we
will need to engage patients, caregivers, multidisciplinary
healthcare providers, and our health network technology
partners to design interventions to streamline care to improve patient satisfaction and overall experience.
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